Application of Neurogenomics and Molecular Technologies for Alzheimer's and Parkinson’s Diseases
Open Access
- 21 May 2026
- journal article
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 01_Special (19) , 982
Abstract
Neurogenomics is an interdisciplinary field that focuses on studying the genetic fundamentals of neurodegenerative diseases, seeking to understand how genetic variations contribute to the onset, progression, and severity of diseases such as Alzheimer's and Parkinson's diseases. This review aims to investigate and critically assess the evolving roles of neurogenomics and molecular technologies in the understanding, early identification, and treatment advancement for Alzheimer's and Parkinson's diseases. Neurogenomics aims to find specific genetic mutations, polymorphisms, and epigenetic variables to provide new therapeutic targets and potential biomarkers for early diagnosis. Molecular diagnosis plays a pivotal role in identifying genetic risk factors and distinguishing between different neurodegenerative conditions. This article seeks to emphasize recent progress in gene expression profiling, biomarker identification, and transgenic model research, while addressing the therapeutic significance of tools such as PCR, ISH, and Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR). The study highlights how the integration of genomic techniques with molecular biomarkers can enhance disease prognosis, patient stratification, and individualized therapy approaches for neurological diseases.Keywords
This publication has 24 references indexed in Scilit:
- Alzheimer's disease current therapies, novel drug delivery systems and future directions for better disease managementJournal of Controlled Release, 2024
- The pathogenesis of Parkinson's diseaseThe Lancet, 2024
- Alzheimer's and Parkinson's disease therapies in the clinicBioengineering & Translational Medicine, 2022
- Biomarkers in Parkinson’s Disease2021
- A current view on Tau protein phosphorylation in Alzheimer's diseaseCurrent Opinion in Neurobiology, 2021
- CRISPR-based diagnosticsNature Biomedical Engineering, 2021
- Parkinson disease-associated cognitive impairmentNature Reviews Disease Primers, 2021
- Exploring the Role of PSEN Mutations in the Pathogenesis of Alzheimer’s DiseaseNeurotoxicity Research, 2020
- Concepts and classification of neurodegenerative diseases2018
- Brain Imaging in Alzheimer DiseaseCold Spring Harbor Perspectives in Medicine, 2012